Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | Open-label, Phase I/II Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Anticancer Activity of Avelumab in Pediatric Subjects From Birth to Less Than 18 Years of Age With Refractory or Relapsed Solid Tumors and Lymphoma |
|---|---|
| Disease/Condition | Solid Tumor,Pediatric Hematology/Oncology,Lymphoma,Lymphatic and Spleen Diseases,Neoplasms,Lymphoproliferative Disorders,Immune System Diseases |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | David Loeb, MD |
| Contact Name | David Loeb, MD |
| Contact Email | david.loeb@einstein.yu.edu |
| Protocol Number | 17-10-398Q-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | Yes |
| Sub-Specialty | Cancer Related - Malignancy |
| Adult, Pediatric, Both | Pediatric |
